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Abstracts / International Journal of Surgery 8 (2010) 501–578 525Laparotomywas required for 10 episodes (20%). 27 episodes (55%) required
minor operation such as removal of F.B or closure of skin laceration. Of the
two patients admitted with insertion of foreign body per rectum, one
required laparotomy to retrieve a glass.INTRACORPOREAL ANASTOMOSIS IN RIGHT HEMICOLECTOMY – A SAFE
PROCEDURE
M. Gowda, K. Maude, J.P. Grifﬁth. Bradford Royal Inﬁrmary
Introduction: Laparoscopic extracorporeal anastomosis (ECA) in right
hemicolectomy has been routinely performed in our department since
February 2003. Intracorporeal anastomosis (ICA) was introduced in April
2007 allowing specimen retrieval via a smaller left iliac fossa incision. We
compare our experience of ICA with ECA.
Method: Prospective audit of 73 consecutive patients undergoing right
hemicolectomy was performed. Data collected were patient demo-
graphics, BMI, duration of operation, type of anastomosis, previous
surgery, conversion rate, histology, operative blood loss, length of stay and
post operative complications. Statistical analysis was performed using
mann-whitney test.
Results: 48 ECA and 25 ICA were performed. There was no signiﬁcant
difference in sex distribution (ECA; male 24, female 24 vs. ICA; male 9,
female 16 (p ¼ 0.254)) and median age at operation (ECA; 72.5 years vs.
ICA; 70 years (p ¼ 0.898)). ECA took longer than ICA; median 163.5 vs. 142
minutes respectively (p¼ 0.041). Length of staywas signiﬁcantly shorter in
those undergoing ICA (ICA; 4 days vs. ECA; 6 days (p<0.001)). There was
one anastomotic leak in the ECA group.
Discussion: The ICA offers a comparable, safe alternative to ECA in lapa-
roscopic right hemicolectomy. Reduced hospital stay is an added advan-
tage possibly related to a smaller lower abdominal incision.LUMBAR CHEMICAL SYMPATHECTOMY IN PERIPHERAL VASCULAR
DISEASE: DOES IT STILL HAVE A ROLE? – A NATIONAL SURVEY
P.N. Nesargikar, M.K. Ajit, J. Wilmot, B.J. Nichols, P.S. Eyers,
J.F. Chester. Taunton and Somerset NHS Trust
Introduction: Lumbar chemical sympathectomy(LCS)is used principally
in inoperable peripheral vascular disease (PVD) to alleviate symptoms of
rest pain. No guidelines currently exist for its use in PVD. The aim of this
study was to evaluate the role of LCS with regards to indications and
outcomes in the UK and Irish vascular practice.
Methods: Speciﬁcally designed questionnaires were sent to Vascular
Surgical Society members.Questions related to their current use of LCS
including indications, outcome parameters, use in diabetics and compli-
cations encountered.
Results: 490 questionnaires were sent out and 242 responses(49%) were
received. Responses covered 84 vascular departments. 75% of respondents
felt that LCS still had a role in current practice. 78% performed less than 10
procedures per year. Inoperable PVD with rest pain was the main indica-
tion in over 80% of responses, with 27% using it for treatment of ulcers.
Only 21% used LCS in diabetics. Symptomatic clinical improvement was
used to assess outcome following LCS in 96% of responses.
Conclusion: Our study shows that majority continue to use it, though
evidence for its efﬁcacy has been equivocal. Clear guidelines regarding
patient selection and indication can redeﬁne the role of LCS in peripheral
vascular disease.PATTERNS OF RECURRENCE FOLLOWING GASTRO-OESOPHAGECTOMY –
IS THERE A ROLE FOR ADJUVANT RADIOTHERAPY?
N.C. Carter, S. Mercer, N. Davies, M. Bayne, T. Geldart. Royal Bournemouth
Hospital
Aims: Circumferential resection margin (CRM) involvement is an inde-
pendent prognostic marker for recurrence following surgery, and it is
speculated that adjuvant radiotherapy following R1 resection might be of
beneﬁt.
Methods: All patients undergoing oesophagectomy during a 6 year period
at one centre were studied. Data regarding pathology and survival were
collected and analysed. Survival was calculated with Kaplan-Meier
Survival Curves and Log Rank analysis.
Results: 127 Patients had aminimum of 12months follow up (median 41).
There were 80 (63%) R0 resections and 47(37%) R1 resections. 9 patients
were excluded from analysis (8 hospital deaths and 1 incomplete data). R0
median survival was 6.11 years, R119 months (p < 0.0001). 32 (71%) of the
R1 patients recurred during the study period, locoregional in 5 (16%) and
systemic in 27 (84%). 15 (21%) of the R0 resections recurred, 5 (33%)
locoregional and 10 (67%) systemic. Median survival for all those who
recurred was 19 months.
Conclusion: 84% of the R1 recurrences were systemic. This propensity for
distant haematogenous recurrence suggests that adjuvant radiotherapy to
the tumour bed would add little to survival, even in those with an involved
resection margin.
THE EFFECT OF BODY MASS INDEX (BMI) ON OUTCOMES FOLLOWING
OESOPHAGECTOMY
K. Thomson, G. Khera, N. Howes, R. Page, C. Magee. Liverpool Heart and
Chest Hospital
Introduction: Morbid obesity is a signiﬁcant risk factor for oesophageal
cancer and may contribute to poorer outcomes following oesophagectomy
due to surgical and post-operative difﬁculties. We investigated the effect of
BMI on outcomes following oesophagectomy.
Methods: A prospective database of all oesophagectomies performed at
a collaborative upper GI/thoracic cancer centre from 2002 was analysed.
Endpoints were 5-year survival, length of stay and in-hospital mortality.
Statistical analysis was performed using the Kaplan-Meier, Chi squared
and Mann-Whitney U(MWU) tests.
Results: 326 cases were identiﬁed. There was no difference in in-hospital
mortality for themorbidly obese (7%v 7% p¼ 0.97 Chi Squared) or length of
stay (median 13 days v 13 days, p ¼ 0.87 MWU) in the morbidly obese.
Similar ﬁndings were found with the obese (BMI>30) and overweight
(BMI>25). However, in-hospital mortality and length of stay were signif-
icantly higher for those with a BMI<20. Morbid obesity was not associated
with poorer survival following oesophagectomy (p ¼ 0.963), however
patients with BMI<20 did have poorer survival (p ¼ 0.016). Interestingly
therewas a trend towards longer survival in patients with BMI>25 but this
did not reach signiﬁcance (p ¼ 0.07).
Conclusions: Patients with morbid obesity who undergo oesophagec-
tomy can expect similar results to their lighter counterparts.SHOULD INFRAINGUINAL BYPASS SURGERY BE PERFORMED BY
UNSUPERVISED TRAINEES?
K. Akbari, N. Pal. Queen Alexandra Hospital, Portsmouth NHS Trust
